Literature DB >> 14749537

Targeting efficiency of a-1,3-galactosyl transferase gene in pig fetal fibroblast cells.

Dong-Il Jin1, Seung-Hyeon Lee, Jin-Hee Choi, Jae-Seon Lee, Jong-Eun Lee, Kwang-Wook Park, Jeong-Sun Seo.   

Abstract

Animal cloning technology with somatic cells provides an alternative tool to conventional methods for producing transgenic animals. Gene targeting in animals is made feasible using somatic cells with homologous recombination procedure that is a major technique in embryonic stem cells for knocking-out genes. Homologous recombination events in somatic cells are relatively inefficient as compared to those in ES cells, suggesting the need for establishment of efficient gene targeting system in somatic cells. To investigate the efficiency of positive and negative selection for gene targeting in pig fetal fibroblast cells, pig alpha-1,3-galactosyl transferase (13-GT) gene was used for gene targeting. The neomycin phosphotransferase (Neo(r)) and herpes simplex virus-thymidine kinase (HSV-tk) genes were used as positive and negative selection markers in this experiment. Following transfection with targeting DNA construct, the pig fetal fibroblast cells were selected against resistance of G418 and gancyclovir. In DMEM medium containing 5 to 10% serum, Pig fetal fibroblast cells failed to proliferate during drug selection. Increasing serum concentration to 15% of medium yielded less senescent colonies of pig fetal fibroblast cells following drug selection that allowed enough cell colonies to screen genomic DNA. The frequency of gene targeting in pig fetal fibroblast cells with double drug selection was more than 10-fold efficient compared to that with G418 single selection. Double selection method with Neo' and HSV-tk genes could be useful for gene targeting in somatic cells for production of cloned animals carrying targeted endogenous genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14749537     DOI: 10.1038/emm.2003.75

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  7 in total

1.  Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases.

Authors:  Janet Hauschild; Bjoern Petersen; Yolanda Santiago; Anna-Lisa Queisser; Joseph W Carnwath; Andrea Lucas-Hahn; Lei Zhang; Xiangdong Meng; Philip D Gregory; Reinhard Schwinzer; Gregory J Cost; Heiner Niemann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

2.  Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis.

Authors:  N Klymiuk; L Mundhenk; K Kraehe; A Wuensch; S Plog; D Emrich; M C Langenmayer; M Stehr; A Holzinger; C Kröner; A Richter; B Kessler; M Kurome; M Eddicks; H Nagashima; K Heinritzi; A D Gruber; E Wolf
Journal:  J Mol Med (Berl)       Date:  2011-12-15       Impact factor: 4.599

3.  Engineering Large Animal Species to Model Human Diseases.

Authors:  Christopher S Rogers
Journal:  Curr Protoc Hum Genet       Date:  2016-07-01

4.  Use of single stranded targeting DNA or negative selection does not further increase the efficiency of a GGTA1 promoter trap.

Authors:  Benjamin P Beaton; Jiude Mao; Clifton N Murphy; Melissa S Samuel; Randall S Prather; Kevin D Wells
Journal:  J Mol Cloning Genet Recomb       Date:  2013-03-27

5.  Gene targeting in adult rhesus macaque fibroblasts.

Authors:  Daniel T Meehan; Mary Ann Zink; Melissa Mahlen; Marilu Nelson; Warren G Sanger; Shoukhrat M Mitalipov; Don P Wolf; Michel M Ouellette; Robert B Norgren
Journal:  BMC Biotechnol       Date:  2008-03-26       Impact factor: 2.563

Review 6.  Pigs taking wing with transposons and recombinases.

Authors:  Karl J Clark; Daniel F Carlson; Scott C Fahrenkrug
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

7.  Disruption of the myostatin gene in porcine primary fibroblasts and embryos using zinc-finger nucleases.

Authors:  Xian-Ju Huang; Hong-Xiao Zhang; Huili Wang; Kai Xiong; Ling Qin; Honglin Liu
Journal:  Mol Cells       Date:  2014-04-21       Impact factor: 5.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.